GenSight Biologics S.A. (GSGTF)

USD 0.24

(0.0%)

Long Term Debt Summary of GenSight Biologics S.A.

  • GenSight Biologics S.A.'s latest annual long term debt in 2023 was 1.04 Million EUR , down -89.41% from previous year.
  • GenSight Biologics S.A.'s latest quarterly long term debt in 2023 FY was 1.04 Million EUR , down -89.41% from previous quarter.
  • GenSight Biologics S.A. reported annual long term debt of 9.89 Million USD in 2022, up 54.25% from previous year.
  • GenSight Biologics S.A. reported annual long term debt of 6.41 Million USD in 2021, down -44.46% from previous year.
  • GenSight Biologics S.A. reported quarterly long term debt of 6.15 Million EUR for 2023 Q3, up 855.75% from previous quarter.
  • GenSight Biologics S.A. reported quarterly long term debt of 1.04 Million EUR for 2023 FY, down -89.41% from previous quarter.

Annual Long Term Debt Chart of GenSight Biologics S.A. (2023 - 2012)

Created with Highcharts 11.1.0YearsLong Term Debt2012201320142015201620172018201920202021202220230 USD2500000 USD5000000 USD7500000 USD10000000 USD12500000 USD15000000 USD

Historical Annual Long Term Debt of GenSight Biologics S.A. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 1.04 Million EUR -89.41%
2022 9.89 Million USD 54.25%
2021 6.41 Million USD -44.46%
2020 11.55 Million USD 204.79%
2019 3.78 Million USD 10.13%
2018 3.44 Million EUR 13.45%
2017 3.03 Million EUR 3.8%
2016 2.92 Million EUR 369.63%
2015 622.19 Thousand EUR -1.6%
2014 632.33 Thousand EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%

Peer Long Term Debt Comparison of GenSight Biologics S.A.

Name Long Term Debt Long Term Debt Difference
Evofem Biosciences, Inc. 8000.00 USD -13000.0%
BioStem Technologies, Inc. 265.63 Thousand USD -294.526%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 40.301%
Northwest Biotherapeutics, Inc. 20.31 Million USD 94.84%
Regen BioPharma, Inc. 149.61 Thousand USD -600.469%
Acro Biomedical Co., Ltd. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -1210.0%
Skye Bioscience, Inc. 171.23 Thousand USD -512.042%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.991%
Capstone Therapeutics Corp. 8.26 Million USD 87.318%
Adynxx, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 94.988%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -1687.115%
Mesoblast Limited 100.29 Million USD 98.955%
Marizyme, Inc. 667.12 Thousand USD -57.091%
Genus plc 228.2 Million USD 99.541%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.369%
Therapeutic Solutions International, Inc. 5512.00 USD -18913.062%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 52.579%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 25.299%
IMV Inc. 27.39 Million USD 96.175%
AXIM Biotechnologies, Inc. 5.42 Million USD 80.687%
MultiCell Technologies, Inc. 36.43 USD -2876649.931%
ONE Bio Corp. 592.19 Thousand USD -76.968%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 98.116%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 52.92%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 14.683%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -88.968%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -4042.456%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 44.798%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -225.466%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -598.667%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -538.227%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 93.174%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -23418.851%
Genscript Biotech Corporation 287.12 Million USD 99.635%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -729.757%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -357.061%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -356.265%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -98396.241%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -600.469%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -643.262%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 86.598%
SYBLEU INC 300 Thousand USD -249.333%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -183.973%
International Stem Cell Corporation 445 Thousand USD -135.506%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 87.141%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -129.322%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 9.733%
PureTech Health plc 18.25 Million USD 94.258%
Coeptis Therapeutics, Inc. 150 Thousand USD -598.667%
IXICO plc 275 Thousand USD -281.091%
IntelGenx Technologies Corp. 11.83 Million USD 91.148%
Gelesis Holdings, Inc. 26.3 Million USD 96.017%
CSL Limited 11.23 Billion USD 99.991%
Cellectis S.A. 36.21 Million USD 97.106%